LONDON – Atos, a leader in digital transformation, has announced the establishment of a global HPC, AI & Quantum Life Sciences Center of Excellence in partnership with Wellcome Genome Campus in Cambridgeshire, UK. This groundbreaking initiative will provide organizations on Campus, as well as global genome and bio-data institutes, access to cutting-edge HPC, AI & Quantum technologies, according to a press release published on EuropaWire.
The Atos Life Sciences Center of Excellence will enhance the existing Campus compute facilities by offering access to advanced technologies such as Quantum, High Performance Computing, and AI, bolstered by Atos’ products, services, and expertise in these fields. Atos experts will collaborate closely with genome and biological data research scientists to accelerate Life Sciences discovery and innovation.
Dr Julia Wilson, Associate Director at Wellcome Genome Campus, expressed enthusiasm about the partnership, stating, “Delivering greater insight into biodata at superior speeds and efficacy will lead to innovative new methodologies and products, as well as reducing the research-to-product development journey, creating a significant positive impact for various areas of life sciences.”
Dr Jo Mills, Entrepreneurship and Innovation Centre Manager at Wellcome Genome Campus, echoed Dr Wilson’s sentiment, highlighting the potential of innovative technology to advance biodata research and translate it into tangible societal benefits.
The Center will serve as a hub for researchers and technologists worldwide to explore the applications of Quantum, High Performance Computing, and AI through various activities, including proof of concept production, innovation workshops, courses, and conferences.
Atos’ Quantum Learning Machine, the world’s highest-performing commercially available quantum simulator, has already proven its value in enhancing research analysis capabilities for organizations across the globe. Researchers will also benefit from Atos’ BullSequana X supercomputers, which support high-performance computing tasks, including those related to the ongoing fight against Covid-19.
Pierre Barnabé, Senior Executive Vice-President, Head of Big Data & Cybersecurity at Atos, emphasized the transformative potential of Quantum, High Performance Computing, and AI in the life sciences sector. He expressed Atos’ commitment to leveraging its technological expertise in collaboration with research institutes to unlock new opportunities.
Despite operating remotely, the Center is actively supporting researchers worldwide studying various aspects of Covid-19, including the characterization of the SARS-CoV-2 structure and modeling the disease’s spread. Additionally, the Center is developing demos to showcase the value of HPC and AI in modeling cardiovascular anomalies and accelerating the interpretation of medical procedures.
